Literature DB >> 26822366

Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: From cognitive improvement to relapse prevention.

Tara Rezapour1, Elise E DeVito2, Mehmet Sofuoglu3, Hamed Ekhtiari4.   

Abstract

Addiction, as a brain disorder, can be defined with two distinct but interacting components: drug dependency and neurocognitive deficits. Most of the therapeutic interventions in addiction medicine, including pharmacological or psychosocial therapies, that are in clinical use have been mainly focused on directly addressing addictive behaviors, especially drug use and urges to use drugs. In the field of addiction treatment, it is often presumed that drug users' neurocognitive deficits will reverse following abstinence. However, in many cases, neurocognitive deficits are not fully ameliorated following sustained abstinence, and neurocognitive function may further deteriorate in early abstinence. It can be argued that many cognitive functions, such as sustained attention and executive control, are essential for full recovery and long-term abstinence from addiction. Recent advances in cognitive neuroscience have provided scientific foundations for neurocognitive rehabilitation as a means of facilitating recovery from drug addiction. Neurocognitive rehabilitation for drug addicted individuals could be implemented as part of addiction treatment, with highly flexible delivery methods including traditional "paper and pencil" testing, or computer-based technology via laptops, web-based, or smartphones in inpatient and outpatient settings. Despite this promise, there has been limited research into the potential efficacy of neurocognitive rehabilitation as a treatment for drug addiction. Further, many questions including the optimum treatment length, session duration, and necessary treatment adherence for treatment efficacy remain to be addressed. In this chapter, we first introduce cognitive rehabilitation as one of the potential areas to bridge the gap between cognitive neuroscience and addiction medicine, followed by an overview of current challenges and future directions.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Neurocognitive rehabilitation; Neuroplasticity

Mesh:

Year:  2015        PMID: 26822366     DOI: 10.1016/bs.pbr.2015.07.022

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  17 in total

1.  Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients.

Authors:  Caroline A Arout; Andrew J Waters; R Ross MacLean; Peggy Compton; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2018-12-18       Impact factor: 4.530

2.  Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability.

Authors:  William S John; Thomas J Martin; Kiran Kumar Solingapuram Sai; Susan H Nader; H Donald Gage; Akiva Mintz; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2017-12-04       Impact factor: 4.030

3.  Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses.

Authors:  Aaron C Lim; Erica N Grodin; Rejoyce Green; Alexandra Venegas; Lindsay R Meredith; Kelly E Courtney; Nathasha R Moallem; Philip Sayegh; Edythe D London; Lara A Ray
Journal:  Am J Drug Alcohol Abuse       Date:  2020-04-28       Impact factor: 3.829

Review 4.  A Patient-Tailored Evidence-Based Approach for Developing Early Neuropsychological Training Programs in Addiction Settings.

Authors:  Benjamin Rolland; Fabien D'Hondt; Solène Montègue; Mélanie Brion; Eric Peyron; Julia D'Aviau de Ternay; Philippe de Timary; Mikaïl Nourredine; Pierre Maurage
Journal:  Neuropsychol Rev       Date:  2019-01-03       Impact factor: 7.444

Review 5.  Neuropsychological Interventions for Decision-Making in Addiction: a Systematic Review.

Authors:  Antonio Verdejo-García; Miguel A Alcázar-Córcoles; Natalia Albein-Urios
Journal:  Neuropsychol Rev       Date:  2018-09-26       Impact factor: 7.444

Review 6.  Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective.

Authors:  Hamed Ekhtiari; Tara Rezapour; Robin L Aupperle; Martin P Paulus
Journal:  Prog Brain Res       Date:  2017-10-06       Impact factor: 2.453

Review 7.  Cognitive Remediation as an Adjunct Treatment for Substance Use Disorders: A Systematic Review.

Authors:  Talia Nardo; Jennifer Batchelor; Jamie Berry; Heather Francis; Deyyan Jafar; Thomas Borchard
Journal:  Neuropsychol Rev       Date:  2021-04-19       Impact factor: 7.444

8.  Cocaine-specific speed-accuracy trade-off during anti-saccade testing differentiates patients with cocaine use disorder who achieve initial abstinence during treatment.

Authors:  Constanza de Dios; Robert Suchting; Heather E Webber; Jin H Yoon; Luba Yammine; Jessica Vincent; Michael F Weaver; Angela L Stotts; Joy M Schmitz; Scott D Lane
Journal:  J Psychopharmacol       Date:  2021-02-14       Impact factor: 4.153

9.  Neurocognitive Empowerment for Addiction Treatment (NEAT): study protocol for a randomized controlled trial.

Authors:  Hamed Ekhtiari; Tara Rezapour; Brionne Sawyer; Hung-Wen Yeh; Rayus Kuplicki; Mimi Tarrasch; Martin P Paulus; Robin Aupperle
Journal:  Trials       Date:  2021-05-07       Impact factor: 2.279

10.  Cannabidiol promotes neurogenesis in the dentate gyrus during an abstinence period in rats following chronic exposure to methamphetamine.

Authors:  Yasaman Razavi; Fariborz Keyhanfar; Abbas Haghparast; Ronak Shabani; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2021-06-18       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.